Date Filed | Type | Description |
10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/07/2023 |
3
| BIOGEN INC. (See footnotes) has filed a Form 3 on REATA PHARMACEUTICALS INC |
07/05/2023 |
4
| Izzar Rachid (Head of Global Product Strat.) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 244 shares
@ $284.85, valued at
$69.5k
Exercised 504 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 122 shares
@ $284.85, valued at
$34.8k
Exercised 252 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Singhal Priya (Head of Development) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 153 shares
@ $284.85, valued at
$43.6k
Sold 81 shares
@ $282.87, valued at
$22.9k
Exercised 315 restricted stock units
@ $0 |
|
06/28/2023 |
4
| SHERWIN STEPHEN A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
4
| Rowinsky Eric K (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
4
| Mantas Jesus B (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
4
| LANGER SUSAN (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
3
| LANGER SUSAN (Director) has filed a Form 3 on BIOGEN INC. |
06/28/2023 |
4
| HAWKINS WILLIAM A (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
4
| Freire Maria C (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 960 shares
@ $0 |
|
06/28/2023 |
4
| DORSA CAROLINE (Director) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 1,580 shares
@ $0 |
|
05/02/2023 |
4
| Keeney Adam (Head of Corporate Development) has filed a Form 4 on BIOGEN INC.
Txns:
| Granted 2,815 restricted stock units
@ $0 |
|
05/02/2023 |
4
| Gregory Ginger (EVP, Human Resources) has filed a Form 4 on BIOGEN INC.
Txns:
| Sold 2,681 shares
@ $300, valued at
$804.3k
|
|
04/25/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/04/2023 |
4
| Murphy Nicole (Head of Pharm Ops and Tech) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 116 shares
@ $278.03, valued at
$32.3k
Exercised 239 restricted stock units
@ $0 |
|
03/06/2023 |
4
| Singhal Priya (Head of Development) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 543 shares
@ $268.75, valued at
$145.9k
Paid exercise price by delivering 144 shares
@ $268.75, valued at
$38.7k
Exercised 297 restricted stock units
@ $0 Disposed of 341 restricted stock units
@ $0 |
|
02/22/2023 |
4
| Singhal Priya (Head of Development) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 151 shares
@ $278.38, valued at
$42k
Exercised 460 restricted stock units
@ $0 Disposed of 408 restricted stock units
@ $0 |
|
02/22/2023 |
4
| Murphy Nicole (Head of Pharm Ops and Tech) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 233 shares
@ $278.38, valued at
$64.9k
Exercised 480 restricted stock units
@ $0 Disposed of 426 restricted stock units
@ $0 |
|
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 238 shares
@ $278.38, valued at
$66.3k
Exercised 512 restricted stock units
@ $0 Disposed of 454 restricted stock units
@ $0 |
|
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2023 |
4
| ALEXANDER SUSAN H (EVP Chief Legal Off & Corp Sec) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 764 shares
@ $286.3, valued at
$218.7k
Paid exercise price by delivering 701 shares
@ $286.3, valued at
$200.7k
Paid exercise price by delivering 2,737 shares
@ $286.3, valued at
$783.6k
Exercised 2,575 restricted stock units
@ $0 Exercised 1,448 restricted stock units
@ $0 Disposed of 1,770 restricted stock units
@ $0 |
|
02/14/2023 |
4
| Gregory Ginger (EVP, Human Resources) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 648 shares
@ $286.3, valued at
$185.5k
Paid exercise price by delivering 548 shares
@ $286.3, valued at
$156.9k
Paid exercise price by delivering 2,110 shares
@ $286.3, valued at
$604.1k
Exercised 2,158 restricted stock units
@ $0 Exercised 1,132 restricted stock units
@ $0 Disposed of 1,384 restricted stock units
@ $0 |
|
02/14/2023 |
4
| Izzar Rachid (Head of Global Product Strat.) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 462 shares
@ $286.3, valued at
$132.3k
Paid exercise price by delivering 220 shares
@ $286.3, valued at
$63k
Paid exercise price by delivering 642 shares
@ $286.3, valued at
$183.8k
Exercised 1,515 restricted stock units
@ $0 Exercised 453 restricted stock units
@ $0 Disposed of 553 restricted stock units
@ $0 |
|
02/14/2023 |
4
| Kramer Robin (Chief Accounting Officer) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 262 shares
@ $286.3, valued at
$75k
Paid exercise price by delivering 67 shares
@ $286.3, valued at
$19.2k
Paid exercise price by delivering 261 shares
@ $286.3, valued at
$74.7k
Exercised 833 restricted stock units
@ $0 Exercised 228 restricted stock units
@ $0 Disposed of 278 restricted stock units
@ $0 |
|
02/14/2023 |
4
| MCDONNELL MICHAEL R (EVP, CFO) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 1,105 shares
@ $286.3, valued at
$316.4k
Exercised 3,256 restricted stock units
@ $0 |
|
02/14/2023 |
4
| Murphy Nicole (Head of Pharm Ops and Tech) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 685 shares
@ $286.3, valued at
$196.1k
Paid exercise price by delivering 537 shares
@ $286.3, valued at
$153.7k
Paid exercise price by delivering 165 shares
@ $286.3, valued at
$47.2k
Exercised 2,271 restricted stock units
@ $0 Exercised 340 restricted stock units
@ $0 Disposed of 416 restricted stock units
@ $0 |
|
02/14/2023 |
4
| Singhal Priya (Head of Development) has filed a Form 4 on BIOGEN INC.
Txns:
| Paid exercise price by delivering 372 shares
@ $286.3, valued at
$106.5k
Exercised 1,211 restricted stock units
@ $0 |
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|